jcp Videos

Videos

Videos

Utilizing Clinical Pathways Tools at Cone Health

10/31/2023

Featuring John A. Ingoglia, PharmD, BCOP, CPP

Featuring John A. Ingoglia, PharmD, B...

John A. Ingoglia, PharmD, BCOP, CPP, Cone Health, provides an overview of how clinical pathways are utilized at Cone Health and shares some of the latest treatment options for breast cancer.

John A. Ingoglia, PharmD, BCOP,...

10/31/2023

Journal of Clinical Pathways

Videos

The Future of Cancer Care At Home

10/25/2023

Featuring Dan Nardi, CEO

Dan Nardi, CEO of Reimagine Care, details his session on the future of cancer care in the home at the 2023 CPC+CBEx conference.

Dan Nardi, CEO of Reimagine...

10/25/2023

Journal of Clinical Pathways

Videos

How Precision Medicine is Changing Cancer Care

10/25/2023

Featuring Debyani Chakravarty, PhD

Featuring Debyani Chakravarty, PhD ...

Debyani Chakravarty, PhD, from the Memorial Sloan Kettering Cancer Center, details her session on scaling precision medicine for equitable cancer care at the 2023 CPC+CBEx conference.

Debyani Chakravarty, PhD, from...

10/25/2023

Journal of Clinical Pathways

Videos

How Pathways Can Aid in Managing Patient Cost of Care

10/23/2023

Featuring Chevon Rariy, MD

Chevon Rariy, MD, Oncology Care Partners, discusses how clinical pathways can help in providing personalized treatment to patients and managing patient cost of care.

Chevon Rariy, MD, Oncology Care...

10/23/2023

Journal of Clinical Pathways

Videos

Reimagining Clinical Trials in the Community Setting

10/20/2023

Featuring Ivy Altomare, MD

Ivy Altomare, MD, Flatiron Health, discusses the current state of clinical research in community oncology and how technologies and new models are changing clinical research.

Ivy Altomare, MD, Flatiron...

10/20/2023

Journal of Clinical Pathways

Videos

Multiple Ethnicities Study Explores A Connection Between Type 2 Diabetes and Urinary Bladder Cancer

10/12/2023

Featuring David Bogumil

David Bogumil, PhD, details his findings on a connection between type 2 diabetes and urinary bladder cancer for African American, European American, Japanese American, Latin American, and Native Hawaiian populations.

David Bogumil, PhD, details his...

10/12/2023

Journal of Clinical Pathways

Conference Coverage

The Future of AI in Cancer Care

10/08/2023

Featuring Will Shapiro

Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.

Will Shapiro, vice president of...

10/08/2023

Journal of Clinical Pathways

Conference Coverage

AI in Cancer Care: Separating Fact from Fiction

10/06/2023

Featuring James Hamrick, MD

James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.

James Hamrick, MD, discusses his...

10/06/2023

Journal of Clinical Pathways

Conference Coverage

CPC & CBEx Session Preview: Updates from Washington, Healthcare Industry Consolidation, and Cancer Care at Home

10/03/2023

Featuring Barbara McAneny, MD

CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...

CPC & CBEx faculty member...

10/03/2023

Journal of Clinical Pathways

Videos

AI Technology in Oncology Care: Thoughts From The Oncology Institute

10/02/2023

Featuring Daniel Virnich, MD; Yale Podnos, MD; and Nikhil Buduma

Featuring Daniel Virnich, MD; Yale Po...

Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...

Daniel Virnich, MD, CEO of The...

10/02/2023

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Videos

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products